Since inflammation and apoptosis are considered to be important mechanisms involved in dry eye, we aimed to explore the role of IL-20 in the pathogenesis of DED and evaluate the therapeutic potential of the anti-IL-20 monoclonal antibody (mAb) 7E for DED treatment. The gene discussed is IL20; the disease is dry eye syndrome.